These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

91 related articles for article (PubMed ID: 8603965)

  • 1. Invasive pneumococcal infections in human immunodeficiency virus-infected children.
    Mao C; Harper M; McIntosh K; Reddington C; Cohen J; Bachur R; Caldwell B; Hsu HW
    J Infect Dis; 1996 Apr; 173(4):870-6. PubMed ID: 8603965
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Invasive pneumococcal disease among infected and uninfected children of mothers with human immunodeficiency virus infection.
    Farley JJ; King JC; Nair P; Hines SE; Tressler RL; Vink PE
    J Pediatr; 1994 Jun; 124(6):853-8. PubMed ID: 8201466
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Invasive pneumococcal disease among human immunodeficiency virus-infected children, 1989-2006.
    Steenhoff AP; Wood SM; Rutstein RM; Wahl A; McGowan KL; Shah SS
    Pediatr Infect Dis J; 2008 Oct; 27(10):886-91. PubMed ID: 18776825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Invasive pneumococcal infections in children following transplantation in the pneumococcal conjugate vaccine era.
    Olarte L; Lin PL; Barson WJ; Romero JR; Tan TQ; Givner LB; Hoffman JA; Bradley JS; Hultén KG; Mason EO; Kaplan SL
    Transpl Infect Dis; 2017 Feb; 19(1):. PubMed ID: 27862712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The immunogenicity and safety of pneumococcal conjugate vaccine in human immunodeficiency virus-infected Thai children.
    Thanee C; Pancharoen C; Likitnukul S; Luangwedchakarn V; Umrod P; Phasomsap C; Apornpong T; Chuanchareon T; Butterworth O; Puthanakit T
    Vaccine; 2011 Aug; 29(35):5886-91. PubMed ID: 21729732
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Prevalence of human immunodeficiency virus infection, mortality rate, and serogroup distribution among patients with pneumococcal bacteremia at Denver General Hospital, 1984-1994.
    Hibbs JR; Douglas JM; Judson FN; McGill WL; Rietmeijer CA; Janoff EN
    Clin Infect Dis; 1997 Aug; 25(2):195-9. PubMed ID: 9332509
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of the 13-valent pneumococcal conjugate vaccine against invasive pneumococcal disease in South African children: a case-control study.
    Cohen C; von Mollendorf C; de Gouveia L; Lengana S; Meiring S; Quan V; Nguweneza A; Moore DP; Reubenson G; Moshe M; Madhi SA; Eley B; Hallbauer U; Finlayson H; Varughese S; O'Brien KL; Zell ER; Klugman KP; Whitney CG; von Gottberg A;
    Lancet Glob Health; 2017 Mar; 5(3):e359-e369. PubMed ID: 28139443
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic changes in bacteremic pneumococcal disease in patients with human immunodeficiency virus in the era of highly active antiretroviral therapy.
    Grau I; Pallares R; Tubau F; Schulze MH; Llopis F; Podzamczer D; Liñares J; Gudiol F;
    Arch Intern Med; 2005 Jul; 165(13):1533-40. PubMed ID: 16009870
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serotype 6C is associated with penicillin-susceptible meningeal infections in human immunodeficiency virus (HIV)-infected adults among invasive pneumococcal isolates previously identified as serotype 6A in South Africa.
    du Plessis M; von Gottberg A; Madhi SA; Hattingh O; de Gouveia L; Klugman KP;
    Int J Antimicrob Agents; 2008 Nov; 32 Suppl 1():S66-70. PubMed ID: 18723328
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of human immunodeficiency virus infection in pneumococcal bacteremia in San Francisco residents.
    Redd SC; Rutherford GW; Sande MA; Lifson AR; Hadley WK; Facklam RR; Spika JS
    J Infect Dis; 1990 Nov; 162(5):1012-7. PubMed ID: 2230229
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Royal Society of Tropical Medicine and Hygiene Meeting at Manson House, London, 12 December 1996. HIV and pneumococcal infection in Africa. Microbiological aspects.
    Paul J
    Trans R Soc Trop Med Hyg; 1997; 91(6):632-7. PubMed ID: 9509167
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Use of surveillance for invasive pneumococcal disease to estimate the size of the immunosuppressed HIV-infected population.
    Schuchat A; Broome CV; Hightower A; Costa SJ; Parkin W
    JAMA; 1991 Jun; 265(24):3275-9. PubMed ID: 2046109
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A trial of a 9-valent pneumococcal conjugate vaccine in children with and those without HIV infection.
    Klugman KP; Madhi SA; Huebner RE; Kohberger R; Mbelle N; Pierce N;
    N Engl J Med; 2003 Oct; 349(14):1341-8. PubMed ID: 14523142
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risk factors for invasive pneumococcal disease in HIV-infected adults in France in the highly active antiretroviral therapy era.
    Munier AL; de Lastours V; Porcher R; Donay JL; Pons JL; Molina JM
    Int J STD AIDS; 2014 Dec; 25(14):1022-8. PubMed ID: 24676129
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Severe pneumococcal sepsis and meningitis in human immunodeficiency virus-infected adults with sickle cell disease.
    Godeau B; Bachir D; Schaeffer A; Brun-Buisson C; Billy I; Portos JL; Galacteros F
    Clin Infect Dis; 1992 Aug; 15(2):327-9. PubMed ID: 1520768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Invasive bacterial infections in children born to women infected with human immunodeficiency virus type 1.
    Andiman WA; Mezger J; Shapiro E
    J Pediatr; 1994 Jun; 124(6):846-52. PubMed ID: 8201465
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Incidence and risk factors for invasive pneumococcal disease in HIV-infected and non-HIV-infected individuals before and after the introduction of combination antiretroviral therapy: persistent high risk among HIV-infected injecting drug users.
    Harboe ZB; Larsen MV; Ladelund S; Kronborg G; Konradsen HB; Gerstoft J; Larsen CS; Pedersen C; Pedersen G; Obel N; Benfield T
    Clin Infect Dis; 2014 Oct; 59(8):1168-76. PubMed ID: 25038114
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Multistate evaluation of invasive pneumococcal diseases in adults with human immunodeficiency virus infection: serotype and antimicrobial resistance patterns in the United States.
    Fry AM; Facklam RR; Whitney CG; Plikaytis BD; Schuchat A
    J Infect Dis; 2003 Sep; 188(5):643-52. PubMed ID: 12934179
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Risk factors for invasive pneumococcal disease among children less than 5 years of age in a high HIV prevalence setting, South Africa, 2010 to 2012.
    von Mollendorf C; Cohen C; de Gouveia L; Naidoo N; Meiring S; Quan V; Lindani S; Moore DP; Reubenson G; Moshe M; Eley B; Hallbauer UM; Finlayson H; Madhi SA; Conklin L; Zell ER; Klugman KP; Whitney CG; von Gottberg A;
    Pediatr Infect Dis J; 2015 Jan; 34(1):27-34. PubMed ID: 24992122
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Increased risk for and mortality from invasive pneumococcal disease in HIV-exposed but uninfected infants aged <1 year in South Africa, 2009-2013.
    von Mollendorf C; von Gottberg A; Tempia S; Meiring S; de Gouveia L; Quan V; Lengana S; Avenant T; du Plessis N; Eley B; Finlayson H; Reubenson G; Moshe M; O'Brien KL; Klugman KP; Whitney CG; Cohen C;
    Clin Infect Dis; 2015 May; 60(9):1346-56. PubMed ID: 25645212
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.